Related Experiment Video
Updated: Oct 11, 2025
05:57
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
888
Structural modification and antihypertensive activity study of formononetin derivatives
Sai-Jie Zuo1, Dong-Lai Ma1, Jing Li1
1School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
Journal of Asian Natural Products Research
|November 30, 2021
Summary
New formononetin derivatives were synthesized and tested for their ability to relax blood vessels. Two compounds, 3d and 3e, showed significant vasodilative and antihypertensive effects in animal models.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cardiovascular Research
Background:
- Isoflavones are a class of compounds with diverse biological activities.
- Vasodilative and antihypertensive properties are crucial targets for cardiovascular drug development.
- Structure-activity relationships (SAR) guide the design of novel therapeutic agents.
Purpose of the Study:
- To design and synthesize novel formononetin derivatives.
- To evaluate the vasodilative activity of these derivatives.
- To investigate their potential as antihypertensive agents.
Main Methods:
- Synthesis of formononetin derivatives with substituted benzyloxy groups.
- In vitro evaluation of vasodilative activity using a wire myograph system on isolated rat mesenteric arterial rings.
- In vivo assessment of antihypertensive effects in spontaneously hypertensive rats (SHRs).
Main Results:
- Compounds 3d and 3e demonstrated potent vasodilative activity.
- These compounds effectively relaxed rat mesenteric arterial rings pre-contracted with potassium chloride.
- Compounds 3d and 3e exhibited significant antihypertensive effects in SHRs following oral administration.
Conclusions:
- The synthesized formononetin derivatives possess promising vasodilative properties.
- Compounds 3d and 3e represent potential lead compounds for developing new antihypertensive drugs.
- Further SAR studies are warranted to optimize the efficacy and safety of these isoflavone derivatives.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
1.1K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.1K
01:17Antihypertensive Drugs: Action of β1 Blockers
737
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
737
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
561
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
561
01:25Antihypertensive Drugs: Direct Renin Inhibitors
892
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
892
01:28Antihypertensive Drugs: Types of β-Blockers
1.0K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.0K
01:23Antihypertensive Drugs: Vasodilators
773
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
773